MRI Assessment of Pulmonary Edema in Acute Heart Failure
Launched by UNIVERSITY OF ALBERTA · Jun 25, 2019
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to measure how much fluid is in the lungs of people with acute heart failure, a condition where the heart can't pump blood effectively. Researchers are using a special imaging technique called MRI (Magnetic Resonance Imaging) to see how lung fluid levels change during a patient's hospital stay. By understanding these changes, the study aims to find out if higher or lower levels of lung water can help predict a patient’s risk of returning to the hospital or facing serious complications.
To participate in this trial, you need to be at least 18 years old and receiving treatment for acute heart failure. This includes patients who are being given medications to help reduce lung fluid, like diuretics. If you’re interested, you’ll have an MRI scan to measure your lung water shortly after starting treatment. It's important to note that certain factors, like being too ill to safely move to the MRI scanner or having severe dementia, might prevent someone from taking part. This study is currently looking for participants, and it could help improve care for future patients with heart failure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older and willing/able to provide informed consent
- • patients being treated for acute heart failure (including those patients with both reduced and preserved ejection fraction)
- • patients receiving medical therapy for pulmonary edema by current standard of care (including oral or IV diuretics)
- • patients identified within 48 hours of initiation of medical therapy for pulmonary edema, defined as the time of first diuretic (IV or PO) or escalation of existing diuretic therapy administered within the ED or hospital
- Exclusion Criteria:
- • contraindication to MRI
- • patient too critically ill/unstable as per the clinical care team for transport to MRI scanner within the required scanning window
- • moderate to severe dementia
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Ottawa, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials